Adverse effect of calcium-channel blockers, subs encntr

This code signifies a patient experiencing an unintended and undesirable reaction to a calcium-channel blocker medication during a follow-up visit. The adverse effect is not due to an overdose or poisoning, but rather a side effect occurring with therapeutic use. The patient is being seen for ongoing management or evaluation of this previously identified adverse drug event.

Apply this code when a patient presents for continued care of an adverse reaction to a calcium-channel blocker, such as peripheral edema, bradycardia, or hypotension, that was initially documented in a prior encounter. This is appropriate for office visits, hospital follow-ups, or other outpatient settings where the patient's condition related to the adverse effect is being monitored or treated.

• Ensure the documentation clearly states the adverse effect is due to a calcium-channel blocker and that this is a subsequent encounter for its management.
• Always code the specific manifestation of the adverse effect (e.g., R03.0 for hypotension, R60.0 for localized edema) as a primary or secondary diagnosis.
• Distinguish from initial encounters (T46.1X5A) or sequela (T46.1X5S) based on the patient's current stage of care for the adverse effect.